Previous 10 | Next 10 |
It has been a rough five years for shareholders of Endo International as the stock has dropped some 85% in that time frame. The company has started to perform a bit better than expectations recently but is still largely unloved by the analyst firm community. We take an in-depth lo...
Endo Announces Licensing Agreement for Paladin Labs Inc. to Commercialize Abaloparatide in Canada PR Newswire DUBLIN , Jan. 5, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited ...
Radius Health (RDUS) inks agreements with Endo International (ENDP), to register, commercialize, and distribute abaloparatide on an exclusive basis in Canada.Paladin Labs, an operating company of Endo, will be responsible for all commercial activities.Under the terms of the agreements, Paladi...
Agreement incorporates TYMLOS ® and abaloparatide-TD Consideration includes upfront payment, milestones based on clinical, regulatory and commercial progression, as well as royalties Key first step in expanding the global footprint for the abaloparatide asset beyond the...
Endo Aesthetics Launches "Really Cellulite" Campaign The Unbranded Campaign Is Designed to Clear Up Misinformation and Pique Curiosity About Cellulite PR Newswire DUBLIN and MALVERN, Pa. , Jan. 5, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP)...
Endo Launches Authorized Generic Version of Amitiza® (lubiprostone) Capsules in the United States PR Newswire DUBLIN , Jan. 4, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical,...
Endo to Participate at J.P. Morgan 39th Annual Healthcare Conference Canada NewsWire DUBLIN , Dec. 18, 2020 /CNW/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on T...
Merger activity increased last week with five new deals announced. The merger of IHS Markit and S&P Global for $44 billion. The acquisition of Slack Technologies by salesforce.com. For further details see: Merger Arbitrage Mondays: Yet Another Deal Receives A Higher ...
Glenview Capital Management’s 13F portfolio value decreased from $3.63B to $3.19B this quarter. The number of positions increased from 43 to 45. They increased Myriad Genetics, while decreasing Quest Diagnostics, DaVita, and United Rentals during the quarter. The top three ...
John Paulson’s 13F portfolio value increased from $3.13B to $3.21B this quarter. Paulson & Company's largest three positions are Horizon Therapeutics, Bausch Health, and SPDR Gold ETF. The stake in Endo International plc was increased substantially during the quarter. ...
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...